(a)
This subpart implements sections 1842(o), 1847A, and 1847B of the Act and outlines two payment methodologies applicable to drugs and biologicals covered under Medicare Part B that are not paid on a cost or prospective payment system basis.
(b)
Examples of drugs that are subject to the requirements specified in this subpart are:
(1)
Drugs furnished incident to a physician's service; durable medical equipment (DME) drugs.
(2)
Separately billable drugs at independent dialysis facilities not under the ESRD composite rate.
(3)
Statutorily covered drugs, for example—
(ii)
Pneumococcal and Hepatitis B vaccines.
(iv)
Hemophilia blood clotting factor.
(v)
Immunosuppressive drugs.
(vi)
Certain oral anti-cancer drugs.
[69 FR 66424, Nov. 15, 2004, as amended at 70 FR 39093, July 6, 2005]